231 related articles for article (PubMed ID: 9885794)
21. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.
Secchi RL; Sung E; Hedley LR; Button D; Schreiber R
Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701
[TBL] [Abstract][Full Text] [Related]
22. Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist.
Feifel D; Reza TL; Wustrow DJ; Davis MD
J Pharmacol Exp Ther; 1999 Feb; 288(2):710-3. PubMed ID: 9918579
[TBL] [Abstract][Full Text] [Related]
23. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
Barr AM; Powell SB; Markou A; Geyer MA
Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
[TBL] [Abstract][Full Text] [Related]
24. Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: reversal by haloperidol.
Japha K; Koch M
Psychopharmacology (Berl); 1999 Jun; 144(4):347-54. PubMed ID: 10435407
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.
Geyer MA; Krebs-Thomson K; Braff DL; Swerdlow NR
Psychopharmacology (Berl); 2001 Jul; 156(2-3):117-54. PubMed ID: 11549216
[TBL] [Abstract][Full Text] [Related]
26. Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity.
Depoortere R; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1997 Aug; 132(4):366-74. PubMed ID: 9298514
[TBL] [Abstract][Full Text] [Related]
27. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.
Wynn JK; Green MF; Sprock J; Light GA; Widmark C; Reist C; Erhart S; Marder SR; Mintz J; Braff DL
Schizophr Res; 2007 Sep; 95(1-3):134-42. PubMed ID: 17662577
[TBL] [Abstract][Full Text] [Related]
28. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Shilling PD; Richelson E; Feifel D
Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
[TBL] [Abstract][Full Text] [Related]
29. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients.
Swerdlow NR; Braff DL; Taaid N; Geyer MA
Arch Gen Psychiatry; 1994 Feb; 51(2):139-54. PubMed ID: 8297213
[TBL] [Abstract][Full Text] [Related]
30. Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat.
Martin RS; Secchi RL; Sung E; Lemaire M; Bonhaus DW; Hedley LR; Lowe DA
Psychopharmacology (Berl); 2003 Jan; 165(2):128-35. PubMed ID: 12404071
[TBL] [Abstract][Full Text] [Related]
31. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol.
Le Pen G; Moreau JL
Neuropsychopharmacology; 2002 Jul; 27(1):1-11. PubMed ID: 12062902
[TBL] [Abstract][Full Text] [Related]
32. Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome.
Swerdlow NR; Bongiovanni MJ; Tochen L; Shoemaker JM
Psychopharmacology (Berl); 2006 Jun; 186(2):246-54. PubMed ID: 16583235
[TBL] [Abstract][Full Text] [Related]
33. Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment.
Li M; He E; Volf N
Pharmacol Biochem Behav; 2011 Jun; 98(4):559-69. PubMed ID: 21402097
[TBL] [Abstract][Full Text] [Related]
34. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
[TBL] [Abstract][Full Text] [Related]
35. The effects of intra-accumbens neurotensin on sensorimotor gating.
Feifel D; Minor KL; Dulawa S; Swerdlow NR
Brain Res; 1997 Jun; 760(1-2):80-4. PubMed ID: 9237521
[TBL] [Abstract][Full Text] [Related]
36. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
[TBL] [Abstract][Full Text] [Related]
37. Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats.
Swerdlow NR; Talledo J; Sutherland AN; Nagy D; Shoemaker JM
Neuropsychopharmacology; 2006 Sep; 31(9):2011-21. PubMed ID: 16482083
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats.
Furuya Y; Kagaya T; Nishizawa Y; Ogura H
Brain Res; 1998 Jan; 781(1-2):227-35. PubMed ID: 9507144
[TBL] [Abstract][Full Text] [Related]
39. The α2C-adrenoceptor antagonist, ORM-10921, has antipsychotic-like effects in social isolation reared rats and bolsters the response to haloperidol.
Uys M; Shahid M; Sallinen J; Dreyer W; Cockeran M; Harvey BH
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():108-16. PubMed ID: 27381554
[TBL] [Abstract][Full Text] [Related]
40. Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis.
Kohlhaas KL; Bitner RS; Gopalakrishnan M; Rueter LE
Psychopharmacology (Berl); 2012 Apr; 220(4):823-33. PubMed ID: 22038534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
